Age of onset in Huntington's disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes
Brain
.
2017 Jul 1;140(7):e42.
doi: 10.1093/brain/awx122.
Authors
Geerte Stuitje
1
2
,
Martine J van Belzen
2
,
Sarah L Gardiner
1
3
,
Willeke M C van Roon-Mom
3
,
Merel W Boogaard
2
;
REGISTRY Investigators of the European Huntington Disease Network
;
Sarah J Tabrizi
4
,
Raymund A C Roos
1
,
N A Aziz
1
4
Affiliations
1
Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
2
Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
3
Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
4
Department of Neurodegenerative Disease, UCL Huntington's Disease Centre, University College London Institute of Neurology, London, UK.
PMID:
28549075
DOI:
10.1093/brain/awx122
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Huntington Disease*
Peptides
Spinocerebellar Ataxias*
Substances
Peptides
polyglutamine
Grants and funding
200181/Z/15/Z/WT_/Wellcome Trust/United Kingdom